Cargando…
Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease and strongly correlates with the growing incidence of obesity and type II diabetes. We have developed a human-on-a-chip model composed of human hepatocytes and adipose tissue chambers capable of modeling the metabolic factors...
Autores principales: | Slaughter, Victoria L., Rumsey, John W., Boone, Rachel, Malik, Duaa, Cai, Yunqing, Sriram, Narasimhan Narasimhan, Long, Christopher J., McAleer, Christopher W., Lambert, Stephen, Shuler, Michael L., Hickman, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222323/ https://www.ncbi.nlm.nih.gov/pubmed/34162924 http://dx.doi.org/10.1038/s41598-021-92264-2 |
Ejemplares similares
-
Development of a human malaria-on-a-chip disease model for drug efficacy and off-target toxicity evaluation
por: Rupar, Michael J., et al.
Publicado: (2023) -
Differential Monocyte Actuation in a Three‐Organ Functional Innate Immune System‐on‐a‐Chip
por: Sasserath, Trevor, et al.
Publicado: (2020) -
On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships
por: McAleer, Christopher W., et al.
Publicado: (2019) -
A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics
por: Smith, Virginia M., et al.
Publicado: (2021) -
Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression
por: Badu-Mensah, Agnes, et al.
Publicado: (2020)